MHC class II transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity.
Benasciutti E, Mariani E, Oliva L, Scolari M, Perilli E, Barras E, Milan E, Orfanelli U, Fazzalari NL, Campana L, Capobianco A, Otten L, Particelli F, Acha-Orbea H, Baruffaldi F, Faccio R, Sitia R, Reith W, Cenci S.
Benasciutti E, et al.
J Bone Miner Res. 2014 Feb;29(2):290-303. doi: 10.1002/jbmr.2090.
J Bone Miner Res. 2014.
PMID: 24038328
Free article.